Sandbox:Amd: Difference between revisions
Jump to navigation
Jump to search
Line 59: | Line 59: | ||
* [[Hydrocortisone]] -15 to 25 mg PO q daily in 2 to 3 divided dose | * [[Hydrocortisone]] -15 to 25 mg PO q daily in 2 to 3 divided dose | ||
* [[Fludrocortisone]] - 0.1 to 0.2 mg PO q daily | * [[Fludrocortisone]] - 0.1 to 0.2 mg PO q daily | ||
| | |– | ||
|- | |- | ||
|Chronic | |Chronic | ||
Line 84: | Line 84: | ||
| | | | ||
* [[Hydrocortisone]] -15 to 25 mg PO daily in 2 to 3 divided doses | * [[Hydrocortisone]] -15 to 25 mg PO daily in 2 to 3 divided doses | ||
| | |Removing pituitary tumors | ||
|- | |- | ||
|Acute | |Acute | ||
Line 114: | Line 114: | ||
| | | | ||
* I/V 0.9% saline 1-3 liters within 12-24 hours | * I/V 0.9% saline 1-3 liters within 12-24 hours | ||
* I/V Dexamethasone 4 mg bolus, ''or,'' I/V hydrocortisone 50 mg bolus | * I/V [[Dexamethasone]] 4 mg bolus, ''or,'' I/V [[hydrocortisone]] 50 mg bolus | ||
* [[Fludrocortisone]] - 0.1 to 0.2 mg PO q daily after initial stabilization | |||
| | | | ||
|- | |- | ||
! colspan="16" |'''<big>Differentiating Adrenal Insufficiency from other diseases</big>''' | |||
! colspan=" | |||
|- | |- | ||
| | | | ||
Line 132: | Line 132: | ||
* [[Tachycardia]] | * [[Tachycardia]] | ||
* [[Dizziness]] | * [[Dizziness]] | ||
* Nausea/ | * [[Nausea and vomiting|Nausea]]/ [[Nausea and vomiting|vomiting]] | ||
* [[Diarrhea]] | * [[Diarrhea]] | ||
| | | | ||
* Infection | * Infection | ||
# Sepsis- [[pneumonia]] | # Sepsis- [[pneumonia]] | ||
# Waterhouse Friderichsen syndrome-[[meningococcemia]] | # Waterhouse Friderichsen syndrome-[[meningococcemia]] | ||
* Cardiac- [[Congestive heart failure]] (CHF), [[Myocardial infarction]] | * Cardiac- [[Congestive heart failure]] (CHF), [[Myocardial infarction]] |
Revision as of 16:12, 2 October 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Adrenal Insufficiency
Acute/
Chronic |
Disease | Clinical history/findings | Causes | Laboratory findings | Medical therapy | Surgical management | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hypotension | Skin
pigmentation/ findings |
Fatigue | Anorexia/
weightloss |
Abdominal pain | Muscle
weakness |
Other history/
findings |
Hypo
natremia |
Cortisol levels | Gold Standard | Other | |||||
Differentiating amongst adrenal insufficiencies | |||||||||||||||
Chronic | Primary adrenal | + | + | + | + | + | + |
|
+ | Low | Cosyntropin/ ACTH stimulation test |
|
– | ||
Chronic | Secondary adrenal
insufficiency |
± | – | + | + | – | ± |
|
|
– | Normal | Cosyntropin/ ACTH stimulation test |
|
|
Removing pituitary tumors |
Acute | Acute adrenal insufficiency/ Acute adrenal crisis | ++ | ± | + | + | + | ± |
|
+ | Normal to Low | Cosyntropin/ ACTH stimulation test |
|
|
||
Differentiating Adrenal Insufficiency from other diseases | |||||||||||||||
Adrenal hemorrhage/ Waterhouse Friderichsen syndrome | orthostatic | ± | + | ± | + | – |
|
+ | Normal to low | Cosyntropin/ ACTH stimulation test |
|
||||
Congenital adrenal hyperplasia (CAH) | Normal to hypertension | ±
(can be indicator of Uncontrolled CAH) |
– | – | – | – |
|
|
± | Low | Cosyntropin/ ACTH stimulation test |
|
|
||
Syndrome of inappropriate antidiuretic hormone (SIADH) | – | – | – | – | – | – |
|
+ | Normal | Water deprivation test |
|
|
|||
Salt-depletion nephritis/ Salt losing nephropathy | + | – | – | – | + Flank pain | – | + | ↑ | Genetic study | <15:1 BUN:CR |
|
||||
Anorexia nervosa | + | – | + | + | – | + |
|
– | ↑ | Psychiatric condition | – |